Simulation of Hemorrhage Pathogenesis in Mice through Dual Stimulation with Dengue Envelope Protein Domain III-Coated Nanoparticles and Antiplatelet Antibody
Open Access
- 25 May 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (11) , 9270
Abstract
Dengue hemorrhagic fever (DHF) is a severe form of dengue virus (DENV) infection that can lead to abnormal immune responses, endothelial vascular dysfunction, and hemorrhage pathogenesis. The virion-associated envelope protein domain III (EIII) is thought to play a role in the virulence of DENV by damaging endothelial cells. However, it is unclear whether EIII-coated nanoparticles simulating DENV virus particles could cause a more severe pathogenesis than soluble EIII alone. This study aimed to investigate whether EIII-coated silica nanoparticles (EIII-SNPs) could elicit greater cytotoxicity in endothelial cells and hemorrhage pathogenesis in mice compared to EIII or silica nanoparticles alone. The main methods included in vitro assays to assess cytotoxicity and in vivo experiments to examine hemorrhage pathogenesis in mice. EIII-SNPs induced greater endothelial cytotoxicity in vitro than EIII or silica nanoparticles alone. Two-hit combined treatment with EIII-SNPs and antiplatelet antibodies to simulate DHF hemorrhage pathogenesis during secondary DENV infections resulted in higher endothelial cytotoxicity than either treatment alone. In mouse experiments, two-hit combined treatment with EIII-SNPs and antiplatelet antibodies resulted in more severe hemorrhage pathogenesis compared to single treatments of EIII, EIII-SNPs, or antiplatelet antibodies alone. These findings suggest that EIII-coated nanoparticles are more cytotoxic than soluble EIII and could be used to develop a tentative dengue two-hit hemorrhage pathogenesis model in mice. Additionally, our results indicated that EIII-containing DENV particles could potentially exacerbate hemorrhage pathogenesis in DHF patients who have antiplatelet antibodies, highlighting the need for further research on the potential role of EIII in DHF pathogenesis.Keywords
Funding Information
- National Science and Technology Council, Taiwan (111-2320-B-320-006-MY3, 105-2923-B-320-001-MY3, 107-2311-B-320-002-MY3, TCMMP108-04, TCMMP 111-01, TCAS-112-02, TCAS-111-02)
- Tzu-Chi Medical Foundation (111-2320-B-320-006-MY3, 105-2923-B-320-001-MY3, 107-2311-B-320-002-MY3, TCMMP108-04, TCMMP 111-01, TCAS-112-02, TCAS-111-02)
This publication has 56 references indexed in Scilit:
- Activated protein C ameliorates Bacillus anthracis lethal toxin-induced lethal pathogenesis in ratsJournal of Biomedical Science, 2012
- Maltosylated polyethylenimine-based triple nanocomplexes of human papillomavirus 16L1 protein and DNA as a vaccine co-delivery systemBiomaterials, 2011
- Visible Light Responsive Photocatalyst Induces Progressive and Apical-Terminus Preferential Damages on Escherichia coli SurfacesPLOS ONE, 2011
- Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in miceBlood, 2010
- Antiplatelet autoantibodies elicited by dengue virus non‐structural protein 1 cause thrombocytopenia and mortality in miceJournal of Thrombosis and Haemostasis, 2007
- DengueThe Lancet, 2007
- The Binding Avidity of a Nanoparticle-Based Multivalent Targeted Drug Delivery PlatformChemistry & Biology, 2007
- Facilitation of Cell Adhesion by Immobilized Dengue Viral Nonstructural Protein 1 (NS1): Arginine‐Glycine‐Aspartic Acid Structural Mimicry within the Dengue Viral NS1 AntigenThe Journal of Infectious Diseases, 2002
- Generation of IgM anti-platelet autoantibody in dengue patientsJournal of Medical Virology, 2001
- Shwartzman ReactionSeminars in Thrombosis and Hemostasis, 1990